CompletedPhase 3ACTRN12609000496213

A randomised, double blind, placebo controlled trial of the effectiveness of “post donation” short term iron replacement in female whole blood donors with a daily oral dose of 45 mgs elemental iron

In female whole blood donors aged 18-45 years does 45mg carbonyl iron daily for 56 days reduce the incidence of iron deficiency when compared to a placebo ( no treatment)

Sponsor

Australian Red Cross Blood Service

Enrollment

260 participants

Start Date

Mar 20, 2009

Study Type

Interventional

Conditions

Iron deficiency in female blood donors aged 18-45 years

Summary

The objectives of this trial are to determine whether a post donation 8 week course of 45 mg elemental carbonyl iron in females aged 18 -45: -is effective in replacing iron lost as a consequence of blood donation, - improves the donor’s eligibility to donate at their subsequent 3 monthly visit as determined by their capillary haemoglobin level, and is well tolerated

Eligibility

Sex: FemalesMin Age: 18 YearssMax Age: 45 Yearss

Plain Language Summary

Simplified for easier understanding

This study examines whether taking a short course of iron supplements after donating blood helps female blood donors recover their iron levels faster. Female donors aged 18-45 receive either iron tablets or a placebo after their donation and return for a follow-up blood test at 12 weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

45mg carbonyl iron taken orally once daily for 56 days

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12609000496213